Six to 12 months AED treatment vs 24 months AED treatment: Seizure control Seizure recurrence
It is very uncertain whether six‐ to 12‐month antiepileptic drug treatment changes seizure control (seizure recurrence) compared with 24‐month antiepileptic drug treatment (very low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Six‐ to 12‐month antiepileptic drug treatment vs 24‐month antiepileptic drug treatment Seizure control (seizure recurrence) · people with neurocysticercosis It is very uncertain whether six‐ to 12‐month antiepileptic drug treatment changes seizure control (seizure recurrence) compared with 24‐month antiepileptic drug treatment (very low certainty). Antiepileptic drugs for seizure control in people with neurocysticercosis (2021) · Cochrane Headline outcomes only | OR 1.36 [0.72, 2.57] | 3 studies · 385 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antiepileptic drugs for seizure control in people with neurocysticercosis 2021 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.